Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,092 | 8,505 | 11,027 | 7,405 | 3,536 |
| Depreciation Amortization | 770 | 2,773 | 2,057 | 1,361 | 674 |
| Income taxes - deferred | -76 | -658 | -281 | -182 | -118 |
| Accounts receivable | -560 | -242 | -1,340 | -1,157 | -934 |
| Accounts payable and accrued liabilities | 142 | 9 | 201 | 68 | 117 |
| Other Working Capital | -1,067 | 6,138 | -602 | -931 | 170 |
| Other Operating Activity | 465 | 383 | 1,261 | 1,178 | 862 |
| Operating Cash Flow | $3,766 | $16,908 | $12,323 | $7,742 | $4,307 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -173 | -1,597 | -174 | -114 | -65 |
| Investing Cash Flow | $-173 | $-1,597 | $-174 | $-114 | $-65 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 147 | 302 | 224 | 168 | 53 |
| Dividend Paid | -1,005 | -2,955 | -1,969 | -984 | N/A |
| Financing Cash Flow | $-858 | $-2,653 | $-1,745 | $-816 | $53 |
| Exchange Rate Effect | 243 | 921 | 738 | 629 | 88 |
| Beginning Cash Position | 39,875 | 26,296 | 26,296 | 26,296 | 26,296 |
| End Cash Position | 42,853 | 39,875 | 37,438 | 33,737 | 30,679 |
| Net Cash Flow | $2,978 | $13,579 | $11,142 | $7,441 | $4,383 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,766 | 16,908 | 12,323 | 7,742 | 4,307 |
| Capital Expenditure | -173 | -1,597 | -174 | -114 | -65 |
| Free Cash Flow | 3,593 | 15,311 | 12,149 | 7,628 | 4,242 |